Thus, in untreated prostate cancer patients, serum CGRP level could be a predictor of grading and staging; this does not occur in patients with prostate cancer who received hormonal treatment since this treatment influences the level of CGRP [274]. This evidence concerns the gene CALCA and prostate cancer.